Green Transformation of the Pharmaceutical Industry: Can Continuous Manufacturing Outperform Traditional Production?
Assesses continuous manufacturing (CM) in pharma green transition, comparing efficiency gains with traditional production amid tech/regulatory barriers and ESG impacts.
September 5, 2025
by Aiden
Green Transformation of the Pharmaceutical Industry: Can Continuous Manufacturing Outpace Traditional Production?
In recent years, the green transformation of the pharmaceutical industry has become a widely discussed topic, with continuous manufacturing emerging as one of the key technologies driving this shift.
September 5, 2025
by Aiden
ESG related equipment in the pharmaceutical industry
ESG principles integrate energy-efficient equipment , OHS systems (biosafety cabinets), and digital compliance tools (EBR, BMS) to achieve sustainability and regulatory governance in pharma manufacturing.
June 13, 2025
by Muhammad Asim Niazi
The Global ESG Rules and Regulations in the Pharmaceutical Industry: AstraZeneca Case Study
In the dynamic pharmaceutical sector, where innovation and regulatory compliance have long been the pillars of success, a new disruptive force is emerging: Environmental, Social, and Governance (ESG) principles
April 21, 2025
by David Orchard-Webb
Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital
Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.
December 12, 2024
by PRNewswire
Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused
As the global healthcare system refocuses after the pandemic, a recent report on the global R&D trend 2023 which was put together as a public service by the IQVIA Institute for Human Data Science.
January 2, 2024
by Shruti Talashi
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by South Korea's Ministry...
January 18, 2022
by prnasia
Amgen named to Dow Jones Sustainability World Index for eighth year
Amgen has announced that it has been named to the Dow Jones Sustainability World Index for the eighth consecutive year. Amgen also was named to the DJSI North America Index for the ninth straight year.
December 1, 2021
by EuropeanPharmaceuticalReview
Recro Pharma Appoints Erica Raether as VP of People, Culture and ESG
Raether has 20 years of human resources experience within the biotech and medical device industries.
July 23, 2021
by contractpharma
Samsung Biologics Issues Its First Annual Sustainability Report
Samsung Biologics, the world's leading contract development and manufacturing organization (CDMO), published its first annual sustainability report, consolidating the company's policies for an enhanced ESG management system and related plans.
June 25, 2021
by prnasia
Cryoport Launches ESG Program
Cryoport, Inc., a provider of temperature-controlled supply chain solutions for the life sciences industry, has launched its Environmental, Social & Governance (ESG) initiative.
March 2, 2021
by contractpharma
Communications Team of the Year strengthens its steering panel for the 2019 competition
PharmaTimes are delighted to announce the formation of a dedicated executive steering group (ESG) for 2019. Due to the continued success and expansionof the communications competition, we are delighted to have been able to bring together such an exception
March 28, 2019
by pharmafocusasia